Repurposing and repositioning drugs and devices in cancer care

Clicks: 2
ID: 311776
2022
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #551 of 631 articles by views in science and technology of advanced materials

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 631 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract

One of the several scientific approaches that the Win-Win Movement advocates is to conduct scientific studies of the uses of older drugs, either single, in novel combinations, or for newer indications. This includes terms such as repurposing, repositioning, or reprofiling drugs or indication switching. A considerable reduction in the costs of treatment could be achieved, along with an increase in the discoveries of newer indications of the value of older drugs and devices.

Reference Key
persistent_1771692294_6999e106b4202 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Ahmed Elzawawy
Journal science and technology of advanced materials
Year 2022
DOI
10.1088/978-0-7503-3075-6ch23
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.